Back to Treatments

Treatment

Doxorubicin (as part of multi-agent chemotherapy)

1
Conditions
200
Trials
10K
Participants
25%
Average Safety

Condition Evidence

Hepatoblastoma

200 trials · 10K participants

75% effectiveness · 25% safety
Doxorubicin (as part of multi-agent chemotherapy) | DFDA